Literature DB >> 30811539

Truncating RAX Mutations: Anophthalmia, Hypopituitarism, Diabetes Insipidus, and Cleft Palate in Mice and Men.

Cécile Brachet1, Elena A Kozhemyakina2,3,4,5, Emese Boros1, Claudine Heinrichs1, Irina Balikova6, Julie Soblet7,8,9, Guillaume Smits7,8,9, Catheline Vilain7,8,9, Peter H Mathers2,3,4,5.   

Abstract

CONTEXT: The transcription factor RAX is a paired-type homeoprotein that plays a critical role in eye and forebrain development of vertebrate species. RAX knockout mice have anophthalmia, cleft palate, and an abnormal hypothalamus and display perinatal lethality. In humans, homozygous or compound heterozygous RAX mutations have been reported to cause bilateral microphthalmia or anophthalmia without consistent associated features. Congenital hypopituitarism can be associated with various eye or craniofacial anomalies; however, the co-occurrence of congenital hypopituitarism, anophthalmia, cleft palate, and diabetes insipidus has been very rare.
RESULTS: We report the case of a child with anophthalmia, congenital hypopituitarism, diabetes insipidus, and bilateral cleft lip and palate who had a homozygous frameshift truncating mutation c.266delC (p.Pro89Argfs*114) in exon 1 of the RAX gene. Rax knockout mice show loss of ventral forebrain structures, pituitary, and basosphenoid bone and palate and a misplaced anterior pituitary gland along the roof of the oral cavity.
CONCLUSIONS: Our patient's phenotype was more severe than that reported in other patients. Although most of the previously reported patients with RAX mutations showed either a missense or some less severe mutation in at least one of their RAX alleles, our patient was homozygous for truncating mutations that would yield a severe, null protein phenotype. The severity of the genetic defect, the precise match between the knockout mouse and the patient's endocrine phenotypes, and the prominent roles of RAX in eye and pituitary development and diencephalic patterning suggest that the RAX null mutations could fully account for the observed phenotype.
Copyright © 2019 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30811539      PMCID: PMC6543774          DOI: 10.1210/jc.2018-02316

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

1.  Deletion at 14q22-23 indicates a contiguous gene syndrome comprising anophthalmia, pituitary hypoplasia, and ear anomalies.

Authors:  Leisha D Nolen; David Amor; Ashley Haywood; Luke St Heaps; Chris Willcock; Marija Mihelec; Patrick Tam; Frank Billson; John Grigg; Greg Peters; Robyn V Jamieson
Journal:  Am J Med Genet A       Date:  2006-08-15       Impact factor: 2.802

2.  Rax : developmental and daily expression patterns in the rat pineal gland and retina.

Authors:  Kristian Rohde; David C Klein; Morten Møller; Martin F Rath
Journal:  J Neurochem       Date:  2011-08-08       Impact factor: 5.372

3.  Alu-element insertion in the homeodomain of HESX1 and aplasia of the anterior pituitary.

Authors:  Marie-Laure Sobrier; Irène Netchine; Claudine Heinrichs; Nathalie Thibaud; Marie-Pierre Vié-Luton; Guy Van Vliet; Serge Amselem
Journal:  Hum Mutat       Date:  2005-05       Impact factor: 4.878

4.  Molecular links among the causative genes for ocular malformation: Otx2 and Sox2 coregulate Rax expression.

Authors:  Hiroki Danno; Tatsuo Michiue; Keisuke Hitachi; Akira Yukita; Shoichi Ishiura; Makoto Asashima
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-02       Impact factor: 11.205

5.  Mutations in the human RAX homeobox gene in a patient with anophthalmia and sclerocornea.

Authors:  Vera A Voronina; Elena A Kozhemyakina; Christina M O'Kernick; Natan D Kahn; Sharon L Wenger; John V Linberg; Adele S Schneider; Peter H Mathers
Journal:  Hum Mol Genet       Date:  2003-12-08       Impact factor: 6.150

6.  Confirmation of RAX gene involvement in human anophthalmia.

Authors:  L Lequeux; M Rio; A Vigouroux; M Titeux; H Etchevers; F Malecaze; N Chassaing; P Calvas
Journal:  Clin Genet       Date:  2008-09-09       Impact factor: 4.438

7.  OTX2 mutation in a patient with anophthalmia, short stature, and partial growth hormone deficiency: functional studies using the IRBP, HESX1, and POU1F1 promoters.

Authors:  Sumito Dateki; Maki Fukami; Naoko Sato; Kouji Muroya; Masanori Adachi; Tsutomu Ogata
Journal:  J Clin Endocrinol Metab       Date:  2008-07-15       Impact factor: 5.958

8.  Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features.

Authors:  Erich Roessler; Yang-Zhu Du; Jose L Mullor; Esther Casas; William P Allen; Gabriele Gillessen-Kaesbach; Elizabeth R Roeder; Jeffrey E Ming; Ariel Ruiz i Altaba; Maximilian Muenke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-27       Impact factor: 11.205

9.  Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humans.

Authors:  Daniel Kelberman; Karine Rizzoti; Ariel Avilion; Maria Bitner-Glindzicz; Stefano Cianfarani; Julie Collins; W Kling Chong; Jeremy M W Kirk; John C Achermann; Richard Ross; Danielle Carmignac; Robin Lovell-Badge; Iain C A F Robinson; Mehul T Dattani
Journal:  J Clin Invest       Date:  2006-08-24       Impact factor: 14.808

10.  Mutations in BMP4 cause eye, brain, and digit developmental anomalies: overlap between the BMP4 and hedgehog signaling pathways.

Authors:  Preeti Bakrania; Maria Efthymiou; Johannes C Klein; Alison Salt; David J Bunyan; Alex Wyatt; Chris P Ponting; Angela Martin; Steven Williams; Victoria Lindley; Joanne Gilmore; Marie Restori; Anthony G Robson; Magella M Neveu; Graham E Holder; J Richard O Collin; David O Robinson; Peter Farndon; Heidi Johansen-Berg; Dianne Gerrelli; Nicola K Ragge
Journal:  Am J Hum Genet       Date:  2008-01-31       Impact factor: 11.025

View more
  1 in total

Review 1.  Advances in differential diagnosis and management of growth hormone deficiency in children.

Authors:  Camille Hage; Hoong-Wei Gan; Anastasia Ibba; Giuseppa Patti; Mehul Dattani; Sandro Loche; Mohamad Maghnie; Roberto Salvatori
Journal:  Nat Rev Endocrinol       Date:  2021-08-20       Impact factor: 43.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.